1. Home
  2. IDXX vs ZTS Comparison

IDXX vs ZTS Comparison

Compare IDXX & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEXX Laboratories Inc.

IDXX

IDEXX Laboratories Inc.

HOLD

Current Price

$689.02

Market Cap

54.5B

Sector

Health Care

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$126.15

Market Cap

53.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDXX
ZTS
Founded
1983
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.5B
53.9B
IPO Year
1991
2013

Fundamental Metrics

Financial Performance
Metric
IDXX
ZTS
Price
$689.02
$126.15
Analyst Decision
Buy
Buy
Analyst Count
10
11
Target Price
$700.50
$174.60
AVG Volume (30 Days)
536.9K
6.1M
Earning Date
02-02-2026
02-12-2026
Dividend Yield
N/A
1.69%
EPS Growth
21.65
11.64
EPS
12.60
5.94
Revenue
$4,167,411,000.00
$9,397,000,000.00
Revenue This Year
$12.15
$3.04
Revenue Next Year
$8.72
$4.98
P/E Ratio
$54.61
$21.14
Revenue Growth
8.39
2.68
52 Week Low
$356.14
$115.25
52 Week High
$769.98
$177.40

Technical Indicators

Market Signals
Indicator
IDXX
ZTS
Relative Strength Index (RSI) 43.94 57.01
Support Level $676.06 $121.12
Resistance Level $711.68 $125.53
Average True Range (ATR) 15.70 2.71
MACD -3.86 1.15
Stochastic Oscillator 27.11 99.67

Price Performance

Historical Comparison
IDXX
ZTS

About IDXX IDEXX Laboratories Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: